文献速递临床试验与 GCP医学教育与科研方法

ASCEND PLUS试验中的患者与公众参与及互动:精简去中心化临床试验设计的反思

Patient and public involvement and engagement in the ASCEND PLUS trial: reflections from the design of a streamlined and decentralised clinical trial.
PubMed 文献 · Trials · 2024-08-22

ASCEND PLUS是一项评估口服司美格鲁肽对约2万名英国2型糖尿病患者心血管事件一级预防效果的随机对照试验,采用去中心化直接邀请、招募和随访模式。本文报告患者与公众参与及互动(PPIE)的过程与实施,评估其对试验设计的影响并反思经验教训。PPIE对优化试验设计、成功获得监管与伦理批准及试验实施至关重要,并将贯穿试验全程。

要点

  • PPIE通过6个焦点小组和公众咨询组(PAG)参与ASCEND PLUS设计阶段。
  • PPIE支持参与者选择在线自主完成或经电话/视频与研究护士完成筛查和知情同意。
  • PAG审阅面向参与者的材料并协助选择生活质量评估工具。

核心结论

  • PPIE是ASCEND PLUS不可或缺的组成部分,并将贯穿试验全程,对优化试验设计、成功获得监管与伦理批准以及实施试验至关重要。

研究设计与样本

  • ASCEND PLUS是一项随机对照试验,评估口服司美格鲁肽对约2万名英国2型糖尿病患者心血管事件一级预防的效果。
  • 试验采用去中心化直接邀请、招募和随访模式,依靠在线表格自我完成或与研究护士进行电话或视频通话,无实体站点。
  • PPIE活动由中心协调,在设计阶段包括6个PPIE焦点小组和创建ASCEND PLUS公众咨询组(PAG)。
  • PAG招募充分考虑多样性和包容性,主要由英国各地成年2型糖尿病患者组成,其中两名成员加入试验指导委员会。
  • 指导委员会会议、焦点小组和PAG会议在线进行,另举办两次混合研讨会讨论PPIE活动和试验相关方面。

主要发现

  • PPIE活动对塑造ASCEND PLUS的设计和实施至关重要。
  • 关键示例包括支持参与者选择独立在线完成筛查/知情同意流程,或在电话或视频通话中与研究护士完成。
  • 开发了简明的「初始信息传单」随初始邀请发送,完整信息传单稍后发送给有兴趣加入试验者。
  • PAG审阅了参与者和公众面向材料的内容和格式,包括书面文件、在线筛查表格、动画视频和试验网站,以提升清晰度和可及性,并对生活质量评估工具的选择提供意见。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: ASCEND PLUS is a randomised controlled trial assessing the effects of oral semaglutide on the primary prevention of cardiovascular events in around 20,000 individuals with type 2 diabetes in the UK. The trial's innovative design includes a decentralised direct-to-participant invitation, recruitment, and follow-up model, relying on self-completion of online forms or telephone or video calls with research nurses, with no physical sites. Extensive patient and public involvement and engagement (PPIE) was essential to the design and conduct of ASCEND PLUS. AIM: To report the process and conduct of PPIE activity in ASCEND PLUS, evaluate effects on trial design, reflect critically on successes and aspects that could have been improved, and identify themes and learning relevant to implementation of PPIE in future trials. METHODS: PPIE activity was coordinated centrally and included six PPIE focus groups and creation of an ASCEND PLUS public advisory group (PAG) during the design phase. Recruitment to these groups was carefully considered to ensure diversity and inclusion, largely consisting of adults living with type 2 diabetes from across the UK. Two members of the PAG also joined the trial Steering Committee. Steering Committee meetings, focus groups, and PAG meetings were conducted online, with two hybrid workshops to discuss PPIE activity and aspects of the trial. RESULTS: PPIE activity was critical to shaping the design and conduct of ASCEND PLUS. Key examples included supporting choice for participants to either complete the screening/consent process independently online, or during a telephone or video call interview with a research nurse. A concise 'initial information leaflet' was developed to be sent with the initial invitations, with the 'full' information leaflet sent later to those interested in joining the trial. The PAG reviewed the content and format of participant- and public-facing materials, including written documents, online screening forms, animated videos, and the trial website, to aid clarity and accessibility, and provided input into the choice of instruments to assess quality of life. CONCLUSIONS: PPIE is integral in ASCEND PLUS and will continue throughout the trial. This involvement has been critical to optimising the trial design, successfully obtaining regulatory and ethical approval, and conducting the trial.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. El-Nayir M, Wijesurendra R, Preiss D, et al. Patient and public involvement and engagement in the ASCEND PLUS trial: reflections from the design of a streamlined and decentralised clinical trial. Trials. 2024. PMID: 39175005. doi:10.1186/s13063-024-08393-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。